Literature DB >> 19842402

Genes and cholangiocarcinoma.

Kanlayanee Sawanyawisuth1.   

Abstract

Cholangiocarcinoma (CCA) is a major public health problem in the northeastern part of Thailand where the prevalence of this cancer is highest in the world. It is a slow growing tumor but highly metastatic with a poor prognosis. The traditional habit of eating raw fish, repeated exposure to liver fluke and consumption of nitrosamine-contaminated food are major risk factors. Understanding of carcinogenesis and metastasis of cholangiocarcinoma at the molecular level will provide tools for better prevention, diagnosis and treatment. This review focuses on CCA- associated genes and their possible applications.

Entities:  

Mesh:

Year:  2009        PMID: 19842402

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  6 in total

1.  A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression.

Authors:  Heping Yang; Tony W H Li; Jian Peng; Xiaoli Tang; Kwang Suk Ko; Meng Xia; Maria-Angeles Aller
Journal:  Gastroenterology       Date:  2011-03-24       Impact factor: 22.682

Review 2.  Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Authors:  Tarun Rustagi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-06

3.  MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.

Authors:  Zhen Liu; Zhi-Yuan Jin; Chen-Hai Liu; Fang Xie; Xian-Sheng Lin; Qiang Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.

Authors:  Rattaya Amornpisutt; Siriporn Proungvitaya; Patcharee Jearanaikoon; Temduang Limpaiboon
Journal:  Tumour Biol       Date:  2015-02-05

5.  A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.

Authors:  Surasee Kamlua; Siriporn Patrakitkomjorn; Patcharee Jearanaikoon; Trevelyan R Menheniott; Andrew S Giraud; Temduang Limpaiboon
Journal:  Oncol Rep       Date:  2011-12-07       Impact factor: 3.906

6.  Diagnostic and prognostic serum marker of cholangiocarcinoma (Review).

Authors:  Xiaojun Zeng; Hualin Tao
Journal:  Oncol Lett       Date:  2014-11-10       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.